期刊文献+

肠道菌群在多发性硬化发病机制中的研究进展 被引量:9

Intestinal flora and its pathogenic mechanism in multiple sclerosis
下载PDF
导出
摘要 多发性硬化(MS)是一种中枢神经系统自身免疫性脱髓鞘疾病,其确切发病机制尚不明确。中枢免疫应答紊乱是多发性硬化的重要机制之一,肠道菌群失调可诱导局部免疫应答反应,外周活化的免疫细胞及其分泌的免疫因子随着血液循环穿过血脑屏障到达中枢后,导致中枢异常的免疫应答反应。肠道菌群还可以通过调控中枢神经系统的免疫应答、调节代谢、增加肠道屏障的通透性以及破坏血脑屏障等途径来影响多发性硬化的发生发展过程。本文对肠道菌群在多发性硬化发病过程中的作用机制进行综述,以进一步认识多发性硬化的发病机制,继而为多发性硬化的治疗提供新方向。 Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system, the exact pathogenesis of MS is not clear at the moment. Central immune response disorder is one of the important mechanism of MS. Intestinal flora imbalance may induce local immune response, and later peripheral activated immune cells and their immune factors, with the blood circulation, travel through the blood-brain barrier to the center, resulting in abnormal central immune response. The intestinal flora can also affect the occurrence and development of MS by regulating the immune response of the central nervous system, regulating the metabolism, increasing the permeability of the intestinal barrier and destroying the blood-brain barrier. The present paper tends to review the action mechanism of intestinal flora on the process and pathogenesis of MS, in order to further understanding the pathogenesis of MS and seeking a new direction for the treatment.
作者 鲍彩彩 原铂尧 孙梦娇 王满侠 牛彦霞 亓斐 BAO Cai-cai;YUAN Bo-yao;SUN Meng-jiao;WANG Man-xia;NIU Yan-xia;QI Fei(Department of Neurology,Second Hospital of Lanzhou University,Lanzhou 730000,China)
出处 《解放军医学杂志》 CAS CSCD 北大核心 2018年第8期710-714,共5页 Medical Journal of Chinese People's Liberation Army
基金 甘肃省科技厅国际合作项目(1604WKCA015)~~
关键词 多发性硬化 肠道菌群 免疫应答 multiple sclerosis intestinal flora immune response
  • 相关文献

参考文献3

二级参考文献55

  • 1Lan-JuanLi Zhong-WenWu Dang-ShengXiao Ji-FangSheng.Changes of gut flora and endotoxin in rats with D-galactosamine-induced acute liver failure[J].World Journal of Gastroenterology,2004,10(14):2087-2090. 被引量:19
  • 2Mohajeri M, Farazmand A, Mohyeddin Bonab M, et al. FOXP3 gene expression in multiple sclerosis patients pre-and post mesenchymal stemcell therapy[J]. Iran J Allergy Asthma Immunol, 2011, 10(3): 155-161.
  • 3Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment[J]. Autoimmun Rev, 2010, 9(5): A387-A394.
  • 4Mauri M, Lentini D, Gravati M, et al. Mesenchymal stem cells enhance GABAergic transmission in co-cultured hippocampal neurons[J]. MolCell Neurosci, 2012, 49(4): 395-405.
  • 5Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons[J]. J Neurosci Res,2000, 61(4): 364-370.
  • 6Wynn RF, Hart CA, Corradi-Perini C, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active. CXCR4receptor capable of promoting migration to bone marrow[J]. Blood, 2004, 104(9): 2643-2645.
  • 7Harting MT, Jimenez F, Xue H, et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury[J]. J Neurosurg, 110(6): 1189-1197.
  • 8Schrepfer S, Deuse T, Reichenspurner H, et al. Stem cell transplantation: the lung barrier[J]. Transplant Proc, 2007, 39(2): 573-576.
  • 9Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?[J]. Trends Immunol, 2007, 28(5): 219-226.
  • 10Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation[J]. Mol Ther, 2012, 20(1): 14-20.

共引文献51

同被引文献106

引证文献9

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部